2'-(3-苯氧基苯亚甲基)-2-羟基苯甲酰腙的合成、晶体结构及理论计算

近年来的研究表明,席夫碱化合物具有广泛的生物活性,在生化反应中起到转氨基作用,碳氮双键是该类化合物具有抑菌活性的效应基团,它们在农药、医药及分析试剂等方面已有很好的应用[1-5]。为了进一步探索高效抑菌、抗病毒药物,我们合成了标题化合物。并用波谱法对合成的中间产物及目标产物进行了结构表征,通过X-单晶射线衍射法测定了目标化合物的晶体结构,并对其进行了量子化学研究。1实验与计算方法1.1仪器与试剂PE-2400C元素分析仪;BRUKER EQUINOX-55红外光谱仪(KBr压片);Varian XL200型核磁共振仪,DMSO为溶剂,TMS为内标;GBC-9…     

2'-(1-萘亚甲基)-2-羟基苯甲酰腙的合成、晶体结构及抑菌活性

某些席夫碱化合物具有抗肿瘤、抗菌等生物活性,在生化反应中起到转氨基作用,碳氨双键是该类化合物具有抗菌活性的效应基团。而含-CONHN=CH-基团的酰腙类化合物具有特殊的生物活性和强配位能力,在农药、医药和分析试剂等方面一直是人们广泛研究的对象,某些该类化合物在治疗一些疾病和抑菌方面已有广泛的应用。为了进一步探索高效抗菌药物,本研究组在从事席夫碱及腙类化合物的合成、生物活性的测定等工作中合成了标题化合物;并测定了标题化合物对枯草芽孢杆菌、肺炎克氏菌、铜绿脓杆菌、大肠杆菌和金黄色葡萄球菌的抑菌活性。     

2′-(2-噻吩亚甲基)-2-羟基苯甲酰腙钴(Ⅲ)配合物的合成、表征及晶体结构

In ethanol, a mononuclear cobalt(Ⅱ) complex incorporating 2′-(2-Thienylidene)-2-Hydroxybenzoylhydra-zide has been synthesized and characterized by IR, UV-Vis, elemental analysis and X-ray crystal structure analysis. The crystal belongs to triclinic system, space group P1 with cell constant, a=1.230 69(10) nm, b=1.329 18(11) nm, c=1.330 56(11) nm, α=113.702(2)°, β=91.590(2)°, γ=100.846(2)°, V=1.944 4(3) nm³, Z=2, μ=0.662 mm^-1, D_c=1.482 g·cm^-3, F(000)=896, R_int=0.048 7. The crystal structure shows an anionic didentate ligand O and N donors in this work. The cobalt(Ⅲ) atom is hexacoordinated with oxygen atom from keto group and nitrogen atom from amide to form a cobalt atom for the core octahedral structure. CCDC: 748882.     

三(3-羟基黄酮)合铝(Ⅲ)的合成及晶体结构

合成了三(3-羟基黄酮)合铝(Ⅲ),制得[Al(C₁₅H₉O₃)₃]₂·2CHCl₃·8H₂O晶体,X射线衍射结果表明:其结构属于三方晶系,空间群为R3.晶胞参数:a=b=1.6558(3)nm,c=3.6465(20)nm,α=β=90°,γ=120°,V=8.65608(0.00586)nm₃,D_c=1.45g/cm³,μ(MoKα)=3.20cm^-1,F(000)=3924.分子中每个3-羟基黄酮以其独特的酮基和羟基同时与Al³⁺配位,3个配体中的6个配位氧原子形成扭曲的配位八面体.     

3-(2-羟基苯基)-5-苯基-6-乙氧羰基-2-环己烯酮的合成与晶体结构

合成了3-(2-羟基苯基)-5-苯基-6-乙氧羰基-2-环己烯酮.通过元素分析、红外光谱、紫外光谱、核磁共振氢谱和质谱对其组成和结构进行了表征.利用X射线衍射分析方法测定了它的晶体结构.该化合物的晶体属单斜晶系,空间群P21/c,a=1.41946(17)nm,b=0.58445(7)nm,c=2.1756(3)nm,β=104.795(2)°,V=1.7450(4)nm3,Z=4,Dc=1.280 g·cm-3,F(000)=712,μ=0.088mm-1,R1[I＞2σ(I)]=0.0627,wR2[I＞2σ(I)]=0.1484.晶体结构测定结果表明化合物分子中的环己烯部分为半椅式构象,分子间通过氢键形成具有16元环的二聚体.     

对硝基苯甲醛缩对羟基苯甲酰腙的合成与晶体结构

合成了一种新的对硝基苯甲醛缩对羟基苯甲酰腙晶体;利用红外光谱、紫外光谱和元素分析对其进行了表征,并利用单晶X射线衍射测定了其晶体结构.结果表明,该晶体属于单斜晶系,P2(1)/n空间群;晶胞参数a=0.766 17(2)nm,b=1.357 3(3)nm,c=1.256 0(3)nm,β=92.71(3)°,V=1.304 7(4)nm3,Z=4,Dc=1.452 g/cm3,μ=0.109 mm-1.12 593个可观察独立衍射点(I2σ(I))偏离因子R1=0.042 5,wR2=0.142 4,S=1.096.     

3-(水杨酰肼)-丁基-2-酮肟和两个镍的酮肟配合物的合成和晶体结构

合成了3-(水杨酰肼)-丁基-2-酮肟H₂L(1，C₁₁H₁₃N₃O₃)和2个镍的3-(水杨酰肼)-丁基-2-酮肟化合物[Ni(HL)(CH₃COO^-)(C₅H₅N)₂](2)和[Ni(HL)₂]·2C₃H₇NO（3）。化合物1晶体属单斜晶系，空间群为P2₁/n，晶体学参数为：a=0.451 87(2) nm，b=2.086 8(1) nm，c=1.224 48(9) nm，β=94.974(3)°，V=1.150 3(1) nm³，Z=4，D_c=1.358 g·cm^-3，μ=0.101 mm^-1，F(000)=496，R=0.0435，wR=0.142 5。化合物2晶体属单斜晶系，空间群为P2₁/n，晶体学参数为：a=1.362 39(8) nm，b=1.345 37(6) nm，c=1.438 54(7) nm，β=113.138(3)°，V=2.424 6(2) nm³，Z=4，D_c=1.398 g·cm^-3，μ=0.843mm^-1，F(000)=1 064，R=0.042 4，wR=0.116 6。化合物3晶体属单斜晶系，空间群为P2₁/c，晶体学参数为：a=1.104 22(7) nm，b=2.860 1(1) nm，c=1.114 13(7)nm，β=114.589(5)°，V=3.199 5(3) nm³，Z=4，D_c=1.398 g·cm^-3，μ=0.667 mm^-1，F(000)=1 416，R=0.057 6，wR=0.1535。在化合物1晶体中，酮肟分子之间通过分子间氢键形成二维网状结构。在化合物2中，每个镍(Ⅱ)离子由1个3-(水杨酰肼)-丁基-2-酮肟的2个氮原子和1个氧原子，2个吡啶分子中的2个氮原子和1个乙酸根中的1个氧原子形成畸变的NiN₄O₂八面体配位构型，存在分子内氢键O-H(肟)…O(乙酸根)和O-H(酚)…N(酰肼)。在化合物3晶体中，每个镍(Ⅱ)离子由2个3-(水杨酰肼)-丁基-2-酮肟的4个氮原子和2个氧原子配位，形成畸变的NiN₄O₂八面体配位构型。晶体中存在O-H…O和O-H…N两种分子内氢键和O-H…O分子间氢键。     

2′-(4-氟基苯亚甲基)-3，5-二羟基苯甲酰腙Ni(Ⅱ)配合物的合成、表征、晶体结构及光谱性质

In ethanol, a new mononuclear nickel(Ⅱ) complex incorporating Schiff base ligands, [NiL₂](DMF)₄ (HL=2′-(4-fluorobenzylidene)-3,5-dihydroxybenzoylhy drazide) has been synthesized and characterized by IR, UV-Vis, elemental analysis and X-ray crystal structure analysis. The single crystal structure has been determined by single-crystal X-ray diffraction structure analysis. The crystal belongs to monoclinic system, space group P2₁/c with a=1.617 3(2) nm,b=1.798 5(2) nm, c=0.737 61(10) nm, β=91.953(3)°, V=2.144 3(5) nm³, Z=2, μ=0.526 mm^-1, D_c=1.390 g·cm^-3, F(000)=940, R_int=0.105 3. In the compound nickel(Ⅱ) atom is four-coordinated with two nitrogen atoms from amide and two oxygen atoms from keto group. The complex has the centrosymmetry and the nickel(Ⅱ) ion is located in the center. CCDC: 675522.     

2-(3-羟基-2-吡啶基)-苯并咪唑的合成、晶体结构及光谱研究

在合成2-(3-羟基-2-吡啶基)-苯并咪唑的基础上, 利用NMR (1H, 13C, COSY, HSQC 和HMBC), MS, IR 和UV 进
行了详细表征; 通过X-ray 单晶衍射测定该化合物的晶体结构, 实验结果表明该晶体属于单斜晶系{空间群为P21/c,
a＝14.289(3) Å, b＝10.618(2) Å, c＝12.783(3) Å, β＝93.51(3)°, V＝1935.8(7) Å3, Z＝8}, 很好支持了波谱表征的结果.
2-(3-羟基-2-吡啶基)-苯并咪唑的荧光光谱表明, 该化合物在激发态下存在双质子转移现象, 密度泛函计算结果合理解
释了实验现象.     

N-[1-(取代苯基)乙基]-2-羟基苯甲酰肼的合成、表征及抑菌活性

依据邻羟基二苯醚及芳香肼类化合物的抗菌特性, 以邻羟苯基为分子核心, 酰肼键为桥基, 设计合成了7种未见报道的N-(取代苯基)乙基-2-羟基苯甲酰肼类化合物. 以水杨酸甲酯为原料, 经肼解反应后与取代苯乙酮缩合, 再与硼氢化钠反应制得目标化合物, 化合物结构经IR, ¹H NMR和元素分析等证实. 抗菌活性测试结果表明, 该类化合物对不同菌株的抑菌活性具有明显的选择性和特异性. 当质量浓度为1×10^-4 g/mL时, 化合物3b和3e对大肠杆菌和白色念珠菌的抑菌率高达100%, 有极强的抑菌活性; 所有化合物对金黄色葡萄球菌的抑菌率均大于70%, 有一定的抑菌活性. 构效关系分析结果表明, 苯基中引入Cl或Br等卤原子能显著增强化合物的抑菌活性, 而引入-NO₂及-CH₃基团则会降低其抑菌活性.     

Synthesis and Crystal Structure of （Z）-Methyl-3-methoxy-2-{2-[（4-（E-3-p-tolylacryloyl）phenoxy）methyl]phenyl}acrylate

The title compound,(Z)-methyl-3-methoxy-2-{2-[(4-(E-3-p-tolylacryloyl)phenoxy)-methyl]phenyl}acrylate,was synthesized and determined by X-ray single-crystal diffraction. The crystal belongs to the triclinic system,space group P1 with a = 8.0157(8),b = 12.5748(13),c = 13.3768(14) ,α = 64.770(2),β = 75.720 (2),γ = 89.784(2)°,μ = 0.085 mm-1,Mr = 442.49,V = 1174.1(2) 3,Z = 2,Dc = 1.252 g/cm3,F(000) = 468,T = 294(2) K,R = 0.0603 and wR = 0.1498 for 2644 observed reflections with I 2σ(I). X-ray diffraction analysis reveals that the single crystal contains strong non-classical hydrogen bonds. The preliminary bioassay showed that the title compound exhibits inhibitory activity against the Pseudoperoniospora cubensis and Rhizoctonia solani at the test concentration of 200 mg/L.     

Synthesis and Crystal Structure of [2-Hydroxy- 5-（4-hydroxy-3-phenyliminomethylbenzyl）-benzylidene]-phenyl-amine

The title compound [2-hydroxy-5-（4-hydroxy-3-phenyliminomethyl-benzyl）-benzylidene]-phenyl-amine （C27H22N2O2, Mr = 406.47） was synthesized by 5,5′-methylene-bissalicylal- dehyde with aminobenezene, and its crystal structure was determined by single-crystal X-ray diffraction. The crystal belongs to the monoclinic system, space group C2/c with a = 4.4026（6）, b = 1.501（13）, c = 0.95818（12） nm, β = 90.868（2）°, V= 4.2813（9） nm^3, Z= 8, Dc= 1.292 g/cm^3,μ = 0.010, F（000） = 1744, R = 0.0576 and wR = 0.1450 for 3766 observed reflections with I 〉 2σ（I）. X-ray analysis reveals that the molecule has a pair of intramolecular OH…N hydrogen bonds.     

Synthesis and Crystal Structure of (Z)-Ethyl-4-(4-methoxy)benzylidene-2-(3,5-dimethoxypheny-tetrahydrofuran-3,3-dicarboxylate

The title compound (Z)-ethyl-4-(4-methoxy)benzylidene-2-(3,5-dimethoxyphenyl)- tetrahydrofuran-3,3-dicarboxylate has been synthesized, and its crystal structure was characterized by X-ray single-crystal diffraction. The crystal belongs to triclinic, space group P1-, with a = 8.140(3), b = 11.966(4), c = 13.771(5) α = 67.366(4), β = 85.165(5), γ = 75.806(4)°, V = 1200.1(7) 3, Z = 2, C26H30O8, Mr = 470.50, Dc = 1.302 g/cm3, F(000) = 500, λ(MoKα) = 0.71073 , μ = 0.096 mm–1, R = 0.0659 and wR = 0.1841 for 3080 observed reflections (I > 2σ(I)). As a key intermediate of HIV-1 integrase inhibitor, the synthesis and structure confirmation of the title compound are important for further studies.     

Synthesis and Crystal Structure of (E)-2-(1-(2-Hydroxy-4-methoxyphenyl)ethylideneamino)-3-(4-hydroxyphenyl)methyl Propionate

(E)-2-(1-(2-Hydroxy-4-methoxyphenyl)ethylideneamino)-3-(4-hydroxyphenyl)methyl propionate (C22H27O6N, Mr = 401.45) has been synthesized by a condensation reaction of paeonol with tyrosin methyl ester hydrochloride, and its structure was determined by IR, NMR, HR MS and X-ray single-crystal diffraction. The crystal belongs to the monoclinic system, space group P21/c, with a = 11.91291(15), b = 9.49947(12), c = 19.8727(3) , β = 106.1104(15)°, V = 2160.60(5)3, Z = 4, Dc = 1.234 g/cm3, μ = 0.739 mm-1, F(000) = 856, R = 0.0466 and wR = 0.1461 for 3859 observed reflections with (Ⅰ> 2σ(Ⅰ)). In the crystal structure, the title compound is constructed by a centrosymmetric dimmer unit composed of a pair of π-π stacking enantiomers, and such units are linked by intermolecular O(5)-H(5)…O(1) and intramolecular N(1)-H(1)…O(1) hydrogen bonds.     

Synthesis and Crystal Structure of (Z)-Ethyl 5-(phenylamino)-3-(phenylimino)-3H-1,2-dithiole-4-carboxylate

The compound (Z)-ethyl 5-(phenylamino)-3-(phenylimino)-3H-1,2-dithiole-4-carboxylate 3 has been synthesized by the reaction of ethylacetoacetate 1 and phenylisothiocyanate 2. Its structure has been established by ¹H NMR, ¹³C NMR, infrared, mass spectra, and x-ray crystallography.      

Synthesis and Crystal Structure of 3-（2-Hydroxy-phenyl）-5-（2-methylphenyl）-6-thoxycarbonyl-cyclohexen-2-one

1 INTRODUCTION The molecular assembly of one- or multi-dimen-sional aggregation by hydrogen bonds is now an im-portant subject of supramolecular chemistry and crys-tal engineering[1, . Supramolecular structures formed 2]via intermolecular hydrogen bonds X–H…X or C–H…X (X = O, Cl, N, et al.) are very common inorganic compounds[3~12], and they generally possessdifferent properties due to these hydrogen bonds. Concerning about the spectra of benzene-contai-ning…     

Synthesis and Crystal Structure of（E）-Ethyl 2-（4-（2,4-dimethoxybenzylideneamino）-5-（3,4,5-trimethoxyphenyl）-4H-1,2,4-triazol-3-ylthio）acetate

The crystal structure of the title compound(E)-ethyl 2-(4-(2,4-dimethoxy benzylide-neamino)-5-(3,4,5-trimethoxyphenyl)-4H-1,2,4-triazol-3-ylthio)acetate(4,C24H28N4O7S,Mr = 516.17) was synthesized and determined by X-ray single-crystal diffraction.The crystal belongs to the monoclinic system,space group P21/n with a = 13.162(2),b = 8.4506(13),c = 22.602(4) ,β = 99.888(3)°,μ = 0.183 mm-1,V = 2476.5(7)3,Z = 4,Dc = 1.385 g/cm3,F(000) =1088,T = 110(2) K,R = 0.0426 and wR = 0.1216 for 3859 observed reflections with I > 2σ(Ⅰ).     

Synthesis and Crystal Structure of Methyl 3-（5- Bromo-1-ethyl-1H-indole-3-carbonyl）aminopropionate

Methyl 3-(5-bromo-1-ethyl-1H-indole-3-carbonyl)aminopropionate has been syn-thesized by the acylation of 5-bromo-3-trichloroacetylindole with β-alanine methyl ester,followed by alkylation with ethyl iodide,in 82.6% yield.Its crystal structure was gotten and determined by X-ray diffraction method.The crystal is of monoclinic,space group P2 1 /c with a=11.7927(8),b=14.9342(8),c=9.0060(5),β=101.558(6)°,V=1553.93(16)3,Z=4,D c=1.510 g/cm 3,λ=0.71073,μ(MoKα)=2.656 mm-1,M r=353.22 and F(000)=720.The structure was refined to R=0.0401 and wR=0.0825 for 1704 observed reflections with I > 2σ(I).In the crystal structure,intermolecular N(2)-H(2)···O(1) hydrogen bond and weak intermolecular bonds (C(1)-H(1) O(1) and C(10)-H(10B) O(2)) are formed,and π-π stacking also exists.